Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Change in Inventory: 2011-2025

Historic Change in Inventory for Adma Biologics (ADMA) over the last 11 years, with Sep 2025 value amounting to $5.2 million.

  • Adma Biologics' Change in Inventory rose 164.96% to $5.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.9 million, marking a year-over-year increase of 186.31%. This contributed to the annual value of -$2.7 million for FY2024, which is 127.75% down from last year.
  • As of Q3 2025, Adma Biologics' Change in Inventory stood at $5.2 million, which was down 73.01% from $19.3 million recorded in Q2 2025.
  • Over the past 5 years, Adma Biologics' Change in Inventory peaked at $19.3 million during Q2 2025, and registered a low of -$8.0 million during Q3 2024.
  • In the last 3 years, Adma Biologics' Change in Inventory had a median value of $2.0 million in 2025 and averaged $3.0 million.
  • In the last 5 years, Adma Biologics' Change in Inventory skyrocketed by 2,571.53% in 2023 and then slumped by 699.48% in 2024.
  • Over the past 5 years, Adma Biologics' Change in Inventory (Quarterly) stood at $10.6 million in 2021, then plummeted by 96.54% to $366,457 in 2022, then skyrocketed by 2,571.53% to $9.8 million in 2023, then crashed by 116.00% to -$1.6 million in 2024, then soared by 164.96% to $5.2 million in 2025.
  • Its Change in Inventory stands at $5.2 million for Q3 2025, versus $19.3 million for Q2 2025 and $2.0 million for Q1 2025.